Navigating the Shifting Tides: A Look at Small-Cap Growth in Q1 2026

Well, here we are, reflecting on what was certainly an eventful first quarter of 2026 for the markets, and particularly for small-cap growth companies. It's always a dynamic period, isn't it? As managers of the Goldman Sachs Small Cap Growth Fund, we've spent these past three months diligently navigating a landscape that, frankly, continued to present both intriguing opportunities and some familiar headwinds. We aim to share our insights, performance highlights, and indeed, the strategic choices we made during this time.

Let's get right into it. Q1 saw the broader small-cap universe, as represented by benchmarks like the Russell 2000 Growth Index, exhibit a rather interesting choppiness. We observed periods of robust enthusiasm, often quickly followed by profit-taking, particularly as investors grappled with persistent, albeit moderating, inflation figures and the ever-present speculation around central bank interest rate policies. For our fund, while we faced some pressures, we're pleased to report that our disciplined approach helped us largely keep pace with the benchmark, and in some areas, even carve out a modest outperformance thanks to some carefully selected positions.

Our philosophy, as you know, remains steadfast: identify those truly innovative, high-quality small-cap companies that possess durable competitive advantages and strong management teams capable of executing their growth strategies, come what may. We're not chasing fads; instead, we're seeking sustainable, long-term growth stories. This quarter was a fantastic reminder of why that deep, fundamental research is absolutely crucial in the small-cap space – it's where the wheat truly separates from the chaff, allowing us to find tomorrow's leaders today.

Looking at the individual contributors, we saw significant tailwinds from some of our holdings in specialized healthcare technology, particularly those companies innovating in diagnostic tools and personalized medicine. Their solutions, frankly, are addressing critical, unmet needs, and the market recognized that value. Similarly, select software-as-a-service (SaaS) providers, particularly those offering highly targeted, AI-driven solutions to niche industrial sectors, continued to demonstrate impressive revenue growth and margin expansion, proving their essential nature even amidst broader economic caution. It's truly exciting to watch these companies mature.

Of course, it wasn't all smooth sailing. A few of our positions, primarily those in more nascent, capital-intensive growth stages, experienced some pullbacks. This was largely due to investor sentiment shifting towards profitability over pure top-line growth, especially as the cost of capital remained a talking point. Also, a couple of consumer discretionary plays, despite solid fundamentals, faced headwinds as broader economic anxieties potentially tempered consumer spending more than anticipated in the early part of the year. It's a constant balancing act, isn't it? You win some, you learn from others.

Throughout the quarter, we remained highly active in managing the portfolio. We selectively trimmed positions in companies that had reached what we considered to be their fair valuation or where the risk-reward profile had become less compelling. Conversely, periods of market weakness provided excellent opportunities to add to our high-conviction names at more attractive entry points. We also initiated a few new positions in emerging themes, notably within the sustainable materials sector, where we've identified small companies poised for significant expansion as global demand for eco-friendly alternatives continues to surge. It's about being nimble, always.

As we look ahead to the rest of 2026, we remain cautiously optimistic about the prospects for small-cap growth. While volatility might persist – it often does in this segment, let's be honest – we believe that the current environment is actually quite ripe for active managers who can distinguish between fleeting trends and enduring innovation. The small-cap universe is vast, and many exceptional companies are still undervalued, waiting to be discovered. Our commitment to rigorous research and a long-term investment horizon positions us, we believe, to capitalize on these opportunities for our investors.

Thank you for your continued trust and partnership. We appreciate your interest in the Goldman Sachs Small Cap Growth Fund and look forward to sharing our next update.